İdarubisin yüklü manyetik nanoparçacıkların sentezlenmesi ve MCF-7 meme kanseri hücre hattına uygulanması

Download

TVRJeE5USXk.pdf

Date

2012

Author

Gündüz, Güngör
Yakar, Arzu
Gündüz, Ufuk

Metadata

Show full item record

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Item Usage Stats

133
views

233
downloads

Conventional cancer chemotherapies cannot differentiate between healthy and cancer cells, and lead to severe side effects and systemic toxicity. In the last decades, different kinds of controlled drug delivery systems have been developed to overcome these shortcomings of chemotherapeutics. These studies aim targeted drug delivery to tumor side at the right time. Magnetic nanoparticles (MNP) are potentially important in cancer treatment since they can be targeted to tumor site by an externally applied magnetic field. In this study, firstly MNP were synthesized. Obtained particles were covered with biocompatible polyethylene glycol (PEG); and then conjugated with folic acid. Anticancer drug idarubicin was loaded to nanoparticles and drug release studies were performed. Shape and size, crystal and chemical structures, and magnetic properties of synthesized nanoparticles were characterized. Agglomeration tendency of naked nanoparticles was prevented to a reasonable degree by oleic acid addition during the synthesis. All synthesized MNP have been found to exhibit superparamagnetic behavior at 23˚C and 37˚C. Cytotoxic effects of MNP were investigated on MCF-7 breast cancer cell line. Before drug loading, MNP did not have any toxicity in the concentration ranges of 0 – 500 µg/ml while drug loaded nanoparticles led to significant toxicity in a concentration dependent manner. Idarubicin loaded to MNP exhibited more toxicity compared to free idarubicin on MCF-7 cells. Endocytosis of MNP was illustrated by light and confocal microscopy images. The synthesized nanoparticles have been found to be suitable in terms of size, shape, magnetic and cytotoxic properties for drug targeting or other biomedical applications. The obtained results are expected to contribute to in vitro and in vivo cancer chemotherapy studies.

Subject Keywords

Cancer, MCF-7, Drug targeting, Magnetic nanoparticle, Idarubicin

URI

https://app.trdizin.gov.tr/publication/project/detail/TVRJeE5USXk
https://hdl.handle.net/11511/49919

Collections

Department of Biology, Project and Design

Suggestions

OpenMETU
Core

Synthesis of poly (dl-lactic-co-glycolic acid) coated magnetic nanoparticles for anti-cancer drug delivery Tansık, Gülistan; Gündüz, Ufuk; Department of Biology (2012) One of the main problems of current cancer chemotherapy is the lack of selectivity of anti-cancer drugs to tumor cells which leads to systemic toxicity and adverse side effects. In order to overcome these limitations, researches on controlled drug delivery systems have gained much attention. Nanoscale based drug delivery systems provide tumor targeting. Among many types of nanocarriers, superparamagnetic nanoparticles with their biocompatible polymer coatings can be targeted to an intented site by an extern...
Preparation of polyethylene glycol coated magnetic nanoparticles for targeting of cancer cells Keskin, Tuğba; Gündüz, Ufuk; Department of Biology (2012) Conventional cancer chemotherapies cannot differentiate between healthy and cancer cells, and lead to severe side effects and systemic toxicity. In the last decades, different kinds of controlled drug delivery systems have been developed to overcome these shortcomings of chemotherapeutics. Magnetic nanoparticles (MNP) are potentially important in cancer treatment since they can be targeted to tumor site by an externally applied magnetic field. In this study, it is aimed to synthesize folic acid conjugated; ...
Reversal of breast cancer resistance protein mediated multidrug resistance in MCF7 breast adenocarcinoma cell line Urfalı, Çağrı; Gündüz, Ufuk; Department of Biology (2011) Resistance to various chemotherapeutic agents is a major problem in success of cancer chemotherapy. One of the primary reasons of development of multidrug resistance (MDR) is the overexpression of ATP binding cassette (ABC) transporter proteins. Breast cancer resistance protein (BCRP) belongs to ABC transporter family and encoded by ABCG2 gene. BCRP is mainly expressed in MDR1 (P-glycoprotein) lacking breast cancer cells. Overexpression of BCRP leads to efflux of chemotherapeutic agents at higher rates, the...
Multiscale tumor modeling Ünsal, Serbülent; Acar, Aybar Can; Department of Health Informatics (2014) Cancer’s complex behavior decreases success rates of the cancer therapies. The usual steps cancer therapy are, deciding phase of the cancer and planing the therapy according to medical guidelines and there is no room or chance for personalized medicine. Simulation systems that use patient specific data as input and up-to-date scientific evidence as business rules has chance to help clinicians for evidence based personalized medicine practice.In this study our aim is creating a basic model to guide researche...
Idarubicin-loaded folic acid conjugated magnetic nanoparticles as a targetable drug delivery system for breast cancer Gündüz, Ufuk; Tansik, Gulistan; Mutlu, Pelin; Unsoy, Gozde; YAKAR, ARZU; Khodadust, Rouhollah; Gunduz, Gungor (2014-07-01) Conventional cancer chemotherapies cannot differentiate between healthy and cancer cells, and lead to severe side effects and systemic toxicity. Another major problem is the drug resistance development before or during the treatment. In the last decades, different kinds of controlled drug delivery systems have been developed to overcome these shortcomings. The studies aim targeted drug delivery to tumor site. Magnetic nanoparticles (MNP) are potentially important in cancer treatment since they can be target...

Citation Formats

G. Gündüz, A. Yakar, and U. Gündüz, “İdarubisin yüklü manyetik nanoparçacıkların sentezlenmesi ve MCF-7 meme kanseri hücre hattına uygulanması,” 2012. Accessed: 00, 2020. [Online]. Available: https://app.trdizin.gov.tr/publication/project/detail/TVRJeE5USXk.